Proanthocyanidins Attenuation of Chronic Lead-Induced Liver Oxidative Damage in Kunming Mice via the Nrf2/ARE Pathway

Lead is harmful for human health and animals. Proanthocyanidins (PCs), a natural antioxidant, possess a broad spectrum of pharmacological and medicinal properties. However, its protective effects against lead-induced liver damage have not been clarified. This study was aimed to evaluate the protective effect of PCs on the hepatotoxicity of male Kunming mice induced by chronic lead exposure. A total of 70 healthy male Kunming mice were averagely divided into four groups: control group, i.e., the group exposed to lead, the group treated with PCs, and the group co-treated with lead and PCs. The mice exposed to lead were given water containing 0.2% lead acetate. Mice treated in the PCs and PCs lead co-treated groups were given PC (100 mg/kg) in 0.9% saline by oral gavage. Lead exposure caused a significant elevation in the liver function parameters, lead level, lipid peroxidation, and inhibition of antioxidant enzyme activities. The induction of oxidative stress and histological alterations in the liver were minimized by co-treatment with PCs. Meanwhile, the number of Transferase-Mediated Deoxyuridine Triphosphate-Biotin Nick End Labeling (TUNEL)-positive cells was significantly reduced in the PCs/lead co-treated group compared to the lead group. In addition, the lead group showed an increase in the expression level of Bax, while the expression of Bcl-2 was decreased. Furthermore, the lead group showed an increase in the expression level of endoplasmic reticulum (ER) stress-related genes and protein (GRP78 and CHOP). Co-treated with PCs significantly reversed these expressions in the liver. PCs were, therefore, demonstrated to have protective, antioxidant, and anti-ER stress and anti-apoptotic activities in liver damage caused by chronic lead exposure in the Kunming mouse. This may be due to the ability of PCs to enhance the ability of liver tissue to protect against oxidative stress via the Nrf2/ARE signaling pathway, resulting in decreasing ER stress and apoptosis of liver tissue.


Introduction
Lead is a non-essential toxic heavy metal which has been a persistent public health problem in many countries around the world. Lead is an environmental toxicant which causes a broad range of adverse effects in both humans and animals [1]. In the human body, lead mainly accumulates in the nervous system, blood, digestive and cardiovascular systems, and also in the kidney and bone [2][3][4]. Lead has also been shown to inhibit growth [5,6]. Lead can cause oxidative damage in many tissues, GSH, and the activities of GSH-Px and SOD were determined according to the instructions of the manufacturer for the specific kit (Nanjing Jiancheng Institute of Biotechnology). The concentration of MDA was assayed by monitoring thiobarbituric acid reactive substance formation. According to the instructions of the reduced glutathione assay kit (Nanjing Jiancheng Institute of Biotechnology), the concentration of reduced GSH was detected by the Dinitrothiocyano benzene (DNTB) rate colorimetric method.

TUNEL Analysis of Apoptosis
Mice liver paraffin slices were prepared for TUNEL assay, which was performed by using a commercial kit in accordance with the manufacturer's instructions. Briefly, the paraffin slices were fixed with dimethylbenzene for 15 min at the room temperature and washed with absolute ethyl alcohol twice, for three minutes each time, then washed with phosphate-buffered saline (PBS) for the third time, for five minutes. The fixed sections were incubated with 100 µL of 20 µg/mL proteinase K solution for 10 min. Subsequently, the 10 µL 5× reaction buffer, 38 µL ddH 2 O, 1 µL fluorescein isothiocyanate (FITC)-labelled dUTP, and 1 µL terminal deoxynucleotidyl transferase (TdT) enzyme solution was mixed and added to the surface of one slide and incubated at 37 • C, for 1 h, in the dark. The sample was then strained by DAPI for 8 min. The labelled slices were washed and photographed under a fluorescence microscope. The nucleus of any apoptotic cells were brown, and the other nuclei were blue.

Western Blot Assay
The total protein and nuclear protein in 100 mg of the liver tissue of mice were extracted using Radio-Immunoprecipitation Assay (RIPA) lysis solution and a nuclear/cytoplasm protein extraction kit (Beyotime Biotech, Shanghai, China). The Bicinchoninic acid (BCA) protein assay kit (Beyotime, Shanghai, China) was used to determine the protein concentrations, and equivalent amounts of proteins (30 µg/lane) were loaded onto 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (SDS-PAGE). After the proteins were separated by SDS-PAGE, they were transferred to a Modified as polyvinylidene fluoride (PVDF) membrane. Antibodies then were added for rabbit anti-Nrf2 (1:1000), anti-HO-1 (1:1000), anti-γ-GCS (1:500), anti-Bcl-2 (1:1000), anti-Bax (1:1000), and β-actin (1:2000) polyclonal antibodies, and incubated overnight at 4 • C. On the second day, HRP-labeled goat anti rabbit IgG was added and incubated at room temperature for 2 h. An Electrochemical luminescence (ECL) chemical luminescence method was then used to detect the color reaction. Images were acquired and the results of the gray scale image were analyzed using a Bio-Rad gel imaging system. The relative expression levels of proteins in each group were represented by the ratio of the gray value of the target protein and the β-actin.

Gene Expression
The total RNA of the 100 mg of the liver tissue in each group was extracted using TRIzol reagent. Then, the purity and the quantity of the total RNA were measured via the quotient for optical density (OD) at 260/280 nm (1.8-2.0). The 4 µg of total RNA from each sample was treated with DNAse. After DNAse treatment, 3 µg of DNA-free RNA in a total volume of 20 mL was then reverse transcribed into cDNA using MBI Ferments Prime Script RT reagent kit (Burlington, ON, Canada) according to the manufacturer's instructions. The cDNA was used as the template for further quantitative RT-PCR analysis. An ABI 7500 real-time PCR system and the SYBR Green PCR Kit were used to conduct real-time PCR. Each sample had been measured in triplicate. For qRT-PCR reactions, 2 µL product of cDNA, 0.4 µL reverse primers, 0.4 µL forward, 10 µL 2× SYBR ® Premix Ex TaqTM, 6.8 µL of RNase-free water, and 0.4 µL ROX Reference Dye II (50×). The conditions of conducting the PCR reaction included: at the initial stage, denaturing at 95 • C for 5 min, and then denaturing at 95 • C for 15 s, annealing at 56 • C for 30 s, and extension at 72 • C for 30 s. The amount of the template was measured based on the standard curve of quantitative analysis. The primers of Nrf2, γ-GCS, Bcl-2, Bax, GRP78, and CHOP were designed by using Primer 5 software (PREMIER Biosoft company, Palo Alto, CA, USA) (Table 1), and β-actin was employed as a house-keeping gene. The results were analyzed by using the 2 −∆∆CT assay.

Statistical Analyses
All data were processed using SPSS 17 statistical software (IBM, Almon, NY, USA). The significance level of statistic differences between mean values was determined using one-way ANOVA, and a p-value < 0.05 was considered as significant.

The Effect of PC on the Lead Content of Whole Blood and Liver Tissue in Mice
As shown in Table 2, the lead levels detected in the blood and liver tissue of the lead-treated animals were significantly higher compared with the control group (p < 0.05). The experimental model was successful as a system to determine the effects of lead in the presence and absence of PCs in mice. However, lead levels in the blood and liver tissue of mice co-treated with lead and PCs showed no significant difference compared with the animals treated only with lead (p > 0.05), indicating that PCs did not significantly improve the status of the lead in the blood and liver tissue of mice. Table 2. Lead contents in serum and liver of mice in each group (n = 7, X ± s).

The Effect of PCs on the Serum Enzymes of Mice Exposed to Lead
As shown in Table 3, the activities of ALP, ALT, and AST in the serum of the lead-treated group were significantly increased compared to the control group (p < 0.05). However, the activity of three enzymes in the group co-treated with PCs was significantly lower compared with those of the lead-treated group. These activities of these enzymes were not significantly altered in the PCs-only treated group compared with the control group. Co-treatment with PCs significantly reduced the activities of ALP, ALT, and AST (p < 0.05). The ALP, ALT, and AST levels in the lead group were higher than the control group. Table 3. The effect of PCs on serum enzyme levels in mice (n = 7, X ± s).

The Effect of PCs on Oxidative Stress-Related Factors in the Liver of Mice Exposed to Lead
As shown in Table 4, the activities of GSH-Px and SOD significantly increased in the co-treated lead and PC group compared with the group only treated with lead. The MDA levels in the group treated only with lead were also shown to be significantly increased (p < 0.05) and in comparison to PCs-co-treated animals. GSH was significantly increased (p < 0.05) in the group co-treated with lead and PCs compared with the animals only treated with lead. The levels of MDA were also significantly decreased (p < 0.05) in the co-treated group compared with the group treated only with lead. These results indicated that administration of PCs significantly improved the lipid peroxidation damage in the liver tissue in mice exposed to lead. Table 4. The effect of PC on MDA, GSH content, and the activities of GSH-Px and SOD in the liver tissue of mice exposed to lead (n = 7, X ± s).

The Effect of PCs on the Liver Tissue Histopathological Variation of Mice Exposed to Lead
The results of the liver histopathological aspect are shown in Figure 1. Normal histological architecture was observed in the liver sections in the control group ( Figure 1A) and PCs group ( Figure 1B). However, in the lead group, it showed that the hepatic lobule structure was not integrated; the cells were arranged in a discontinuous and loose manner, the central vein tube wall was not integrated; the liver cells around the central vein were disordered; the liver cell size was not uniform, different sizes of vacuoles ere in the sytoplasmic; some nuclei of the hepatocytes were dissolved or pyknotic, and some hepatocytes were swollen and necrotic ( Figure 1C). Animals co-treated with PCs largely improved the lead-induced histopathological changes in the liver tissue, showing clear borders of the hepatic tissue, a decrease of dissolved nuclei, and nuclei pyknosis ( Figure 1D).
1B). However, in the lead group, it showed that the hepatic lobule structure was not integrated; the cells were arranged in a discontinuous and loose manner, the central vein tube wall was not integrated; the liver cells around the central vein were disordered; the liver cell size was not uniform, different sizes of vacuoles ere in the sytoplasmic; some nuclei of the hepatocytes were dissolved or pyknotic, and some hepatocytes were swollen and necrotic ( Figure 1C). Animals co-treated with PCs largely improved the lead-induced histopathological changes in the liver tissue, showing clear borders of the hepatic tissue, a decrease of dissolved nuclei, and nuclei pyknosis ( Figure 1D).

PCs Decreases Lead-Induced Apoptosis of Liver Cells
Compared with the control group (Figure 2A), the TUNEL-positive cells were significantly increased in the lead group (p < 0.05) ( Figure 2C), which was obviously attenuated by the coadministration of PCs ( Figures 2D). However, the TUNEL-positive cells in the PCs group were lower than that in the lead group (p < 0.05).

The Effect of PC on the Expression of Bcl-2 and Bax in the Liver of Mice Exposed to Lead
As we know, Bcl-2 has a role in cells that inhibits the signal which induces apoptosis, Bax has a role in promoting cell apoptosis, and in order to analyze whether PC protects against the toxicity caused by lead related to inhibiting cell apoptosis in the liver of mice, the expression of Bcl-2 and Bax associated with apoptosis was examined, As shown in Figures 3 and 4, compared with the control group, the expression of Bcl-2 mRNA was down-regulated ( Figure 3A) (p < 0.05), whereas the

PCs Decreases Lead-Induced Apoptosis of Liver Cells
Compared with the control group (Figure 2A), the TUNEL-positive cells were significantly increased in the lead group (p < 0.05) ( Figure 2C), which was obviously attenuated by the co-administration of PCs ( Figure 2D). However, the TUNEL-positive cells in the PCs group were lower than that in the lead group (p < 0.05).

PCs Decreases Lead-Induced Apoptosis of Liver Cells
Compared with the control group (Figure 2A), the TUNEL-positive cells were significantly increased in the lead group (p < 0.05) ( Figure 2C), which was obviously attenuated by the coadministration of PCs ( Figures 2D). However, the TUNEL-positive cells in the PCs group were lower than that in the lead group (p < 0.05). As we know, Bcl-2 has a role in cells that inhibits the signal which induces apoptosis, Bax has a role in promoting cell apoptosis, and in order to analyze whether PC protects against the toxicity caused by lead related to inhibiting cell apoptosis in the liver of mice, the expression of Bcl-2 and Bax associated with apoptosis was examined, As shown in Figures 3 and 4, compared with the control 3.6. The Effect of PC on the Expression of Bcl-2 and Bax in the Liver of Mice Exposed to Lead As we know, Bcl-2 has a role in cells that inhibits the signal which induces apoptosis, Bax has a role in promoting cell apoptosis, and in order to analyze whether PC protects against the toxicity caused by lead related to inhibiting cell apoptosis in the liver of mice, the expression of Bcl-2 and Bax associated with apoptosis was examined, As shown in Figures 3 and 4, compared with the control group, the expression of Bcl-2 mRNA was down-regulated ( Figure 3A) (p < 0.05), whereas the expression of Bax mRNA was up-regulated in the lead group ( Figure 3B) (p < 0.05). However, compared with the lead group, the significant up-regulation of Bcl-2 mRNA ( Figure 3A) (p < 0.05) and down-regulation of Bax ( Figure 3B) (p < 0.05) were shown in the group co-treated with lead and PCs. Consistent with real-time PCR, the Western blot findings also showed low expression of Bcl-2 protein in lead-treated mice ( Figure 4A) (p < 0.05), while moderate to strong expression was observed for Bax ( Figure 4B) (p < 0.05). Compared with the lead-treated mice, those co-treated with PCs exhibited improvement, represented by increased expression of anti-apoptotic Bcl-2 protein and moderate expression of the pro-apoptotic protein Bax in the liver of mice ( Figure 4A,B) (p < 0.05).       To analyze whether Nrf2 activation plays a role in PC protection against the toxicity caused by lead, the expression of Nrf2 and Nrf2-target proteins, HO-1 and γ-GCS, in the liver of mice were measured. As shown in Figure 5, compared with the control group, the Western blot results showed that the nuclear Nrf2, HO-1, and γ-GCS protein expression levels in the lead-treated group were increased without significant difference (p > 0.05), while these protein expressions were increased with significant difference in the PCs group (p < 0.05). Compared with the lead group, all of their expressions in the lead/PCs co-treated group were increased with significant difference (p < 0.05) ( Figure 5A-C). Meanwhile, as shown in Figure 6, the RT-PCR results showed that, compared with the control group, the nuclear Nrf2, Ho-1, and γ-GCS mRNA expression levels in the lead-treated group were increased without significant difference (p > 0.05), while these mRNA expressions were increased with significant difference in the PCs group. Compared with the lead group, the mRNA expressions of these genes in the lead/PCs co-treated group and in PCs group were increased with significant difference (p < 0.05).

The Effect of PC on the Expression of Nuclear Nrf2, HO-1, and γ-GCS in the Liver of Mice Exposed to Lead
To analyze whether Nrf2 activation plays a role in PC protection against the toxicity caused by lead, the expression of Nrf2 and Nrf2-target proteins, HO-1 and γ-GCS, in the liver of mice were measured. As shown in Figure 5, compared with the control group, the Western blot results showed that the nuclear Nrf2, HO-1, and γ-GCS protein expression levels in the lead-treated group were increased without significant difference (p > 0.05), while these protein expressions were increased with significant difference in the PCs group (p < 0.05). Compared with the lead group, all of their expressions in the lead/PCs co-treated group were increased with significant difference (p < 0.05) ( Figure 5A-C). Meanwhile, as shown in Figure 6, the RT-PCR results showed that, compared with the control group, the nuclear Nrf2, Ho-1, and γ-GCS mRNA expression levels in the lead-treated group were increased without significant difference (p > 0.05), while these mRNA expressions were increased with significant difference in the PCs group. Compared with the lead group, the mRNA expressions of these genes in the lead/PCs co-treated group and in PCs group were increased with significant difference (p < 0.05).  . The effect of proanthocyanidins (PCs) on the protein expression levels of the nuclear Nrf2, HO-1, and γ-GCS protein in liver tissues of mice exposed to lead. (A) Nuclear erythroid 2-related factor 2 (Nrf2); (B) hemeoxygenase-1 (HO-1); and (C) γ-glutamyl cysteine synthetase (γ-GCS). All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice. results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice. Figure 6. The effect of proanthocyanidins (PCs) on the mRNA expression levels of the nuclear Nrf2, HO-1, and γ-GCS in liver tissues of mice exposed to lead. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.

The Effect of PC on the Expression of GRP78 and CHOP in the Liver of Mice Exposed to Lead
To analyze whether the protective effect of PCs on liver damage was related to inhibiting cell ER stress caused by lead, we measured the expression of GRP78 and CHOP, which were the ER stresstypical related proteins. As shown in Figure 7, compared with the control group, the Western blot results showed that the GRP78 and CHOP protein expression levels in the lead-treated group were increased with significant difference (p > 0.05), while these protein expressions were not significantly different in the PCs group. Compared with the lead group, all of the protein expressions in the lead/PCs co-treated group and PCs group were decreased with significant difference (p < 0.05) ( Figure  7A,B). Meanwhile, as shown in Figure 8, the RT-PCR results showed that, compared with the control group, the Grp78 and Chop mRNA expression levels in the lead-treated group were increased with significant difference (p < 0.05), while these mRNA expressions were not significantly different in the PCs group. Compared with the lead group, the mRNA expression of these genes in lead/PCs cotreated group and in PCs group were decreased with significant difference (p < 0.05). Figure 6. The effect of proanthocyanidins (PCs) on the mRNA expression levels of the nuclear Nrf2, HO-1, and γ-GCS in liver tissues of mice exposed to lead. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.

The Effect of PC on the Expression of GRP78 and CHOP in the Liver of Mice Exposed to Lead
To analyze whether the protective effect of PCs on liver damage was related to inhibiting cell ER stress caused by lead, we measured the expression of GRP78 and CHOP, which were the ER stress-typical related proteins. As shown in Figure 7, compared with the control group, the Western blot results showed that the GRP78 and CHOP protein expression levels in the lead-treated group were increased with significant difference (p > 0.05), while these protein expressions were not significantly different in the PCs group. Compared with the lead group, all of the protein expressions in the lead/PCs co-treated group and PCs group were decreased with significant difference (p < 0.05) ( Figure 7A,B). Meanwhile, as shown in Figure 8, the RT-PCR results showed that, compared with the control group, the Grp78 and Chop mRNA expression levels in the lead-treated group were increased with significant difference (p < 0.05), while these mRNA expressions were not significantly different in the PCs group. Compared with the lead group, the mRNA expression of these genes in lead/PCs co-treated group and in PCs group were decreased with significant difference (p < 0.05). results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice. Figure 6. The effect of proanthocyanidins (PCs) on the mRNA expression levels of the nuclear Nrf2, HO-1, and γ-GCS in liver tissues of mice exposed to lead. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.

The Effect of PC on the Expression of GRP78 and CHOP in the Liver of Mice Exposed to Lead
To analyze whether the protective effect of PCs on liver damage was related to inhibiting cell ER stress caused by lead, we measured the expression of GRP78 and CHOP, which were the ER stresstypical related proteins. As shown in Figure 7, compared with the control group, the Western blot results showed that the GRP78 and CHOP protein expression levels in the lead-treated group were increased with significant difference (p > 0.05), while these protein expressions were not significantly different in the PCs group. Compared with the lead group, all of the protein expressions in the lead/PCs co-treated group and PCs group were decreased with significant difference (p < 0.05) ( Figure  7A,B). Meanwhile, as shown in Figure 8, the RT-PCR results showed that, compared with the control group, the Grp78 and Chop mRNA expression levels in the lead-treated group were increased with significant difference (p < 0.05), while these mRNA expressions were not significantly different in the PCs group. Compared with the lead group, the mRNA expression of these genes in lead/PCs cotreated group and in PCs group were decreased with significant difference (p < 0.05). Figure 7. The effect of proanthocyanidins (PCs) on the protein expression levels of GRP78 and CHOP protein in liver tissues of mice exposed to lead. (A) GRP78; and (B) CHOP. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.  Figure 7. The effect of proanthocyanidins (PCs) on the protein expression levels of GRP78 and CHOP protein in liver tissues of mice exposed to lead. (A) GRP78; and (B) CHOP. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice. Figure 8. The effect of proanthocyanidins (PCs) on the mRNA expression levels of Grp78 and Chop in liver tissues of mice exposed to lead. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.

Discussion
In the present study, the choice of the doses of lead and lead exposure time was based on preliminary experiments by Wang et al. [32,33], which had successfully established the model of chronic lead poisoning in mice. PCs were given to mice at a dose of 100 mg/kg body weight since this was reported to be the most effective dose in previous studies [22,34,35].
The toxicity of the lead has been relatively well studied, particularly in the context of neuro-and nephrotoxicity. As the liver is the central organ in the processing and removal of harmful substances from the body, it is also highly susceptible to damage. In addition, because the liver, via the portal vein, is the first organ exposed to internally-absorbed Pb and is one of the major organs implicated in the storage, biotransformation, and elimination of Pb, the liver must be the target organ of lead and liver will be damaged by lead when lead is taken into the body. Moreover, the liver is the bodyʹs largest detoxification organ, a lot of detoxification enzymes, such as cysteine proteases, will be affected by lead. Previous studies have shown that lead exposure can cause oxidative damage in the liver by inhibiting the activities of antioxidant enzymes, decreasing the concentration of nonenzymatic antioxidants and increasing the concentration of reactive oxygen species [36][37][38]. Our results showed that lead acetate added to the drinking water for six weeks for mice resulted in severe histopathological changes in the liver tissue. In addition, the observed hepatotoxicity caused by lead acetate was accompanied with elevated activities of key liver enzymes, including AST, ALT, and ALP found in serum [39]. Our results of detection of serum biochemical parameters and pathology indicated that lead could accumulate in the liver and cause liver damage, and the reason for damage might be because lead mainly induces reactive oxygen species to attack the target organ and reduces a series of antioxidant enzymes, such as SOD, catalase, and the levels of some antioxidants (GSH) [40,41]. GSH is one of the main antioxidants found in liver tissue and it is central to the detoxification of the heavy metals in the liver. In the current study, it was observed that in the lead-treated group, the activity of GSH-Px was inhibited. As GSH-Px regulated the synthesis of GSH, the level of GSH was also shown to consequently decrease and the content of MDA, which was a product of lipid Chop in liver tissues of mice exposed to lead. All results are expressed as the mean ± SE (n = 7). * p < 0.05, significant change with respect to the control; # p < 0.05, significant change with respect to lead-treated mice.

Discussion
In the present study, the choice of the doses of lead and lead exposure time was based on preliminary experiments by Wang et al. [32,33], which had successfully established the model of chronic lead poisoning in mice. PCs were given to mice at a dose of 100 mg/kg body weight since this was reported to be the most effective dose in previous studies [22,34,35].
The toxicity of the lead has been relatively well studied, particularly in the context of neuro-and nephrotoxicity. As the liver is the central organ in the processing and removal of harmful substances from the body, it is also highly susceptible to damage. In addition, because the liver, via the portal vein, is the first organ exposed to internally-absorbed Pb and is one of the major organs implicated in the storage, biotransformation, and elimination of Pb, the liver must be the target organ of lead and liver will be damaged by lead when lead is taken into the body. Moreover, the liver is the body's largest detoxification organ, a lot of detoxification enzymes, such as cysteine proteases, will be affected by lead. Previous studies have shown that lead exposure can cause oxidative damage in the liver by inhibiting the activities of antioxidant enzymes, decreasing the concentration of non-enzymatic antioxidants and increasing the concentration of reactive oxygen species [36][37][38]. Our results showed that lead acetate added to the drinking water for six weeks for mice resulted in severe histopathological changes in the liver tissue. In addition, the observed hepatotoxicity caused by lead acetate was accompanied with elevated activities of key liver enzymes, including AST, ALT, and ALP found in serum [39]. Our results of detection of serum biochemical parameters and pathology indicated that lead could accumulate in the liver and cause liver damage, and the reason for damage might be because lead mainly induces reactive oxygen species to attack the target organ and reduces a series of antioxidant enzymes, such as SOD, catalase, and the levels of some antioxidants (GSH) [40,41]. GSH is one of the main antioxidants found in liver tissue and it is central to the detoxification of the heavy metals in the liver. In the current study, it was observed that in the lead-treated group, the activity of GSH-Px was inhibited. As GSH-Px regulated the synthesis of GSH, the level of GSH was also shown to consequently decrease and the content of MDA, which was a product of lipid peroxidation, was shown to increase significantly. These results indicate that exposure to lead induced oxidative stress in the liver tissue of mice, which is in close agreement to previous observations reported by Senapati et al. [3] and Newairy et al. [42].
PCs are highly efficient natural antioxidants, their antioxidant activity is 50 times higher than that of vitamin E and 20 times that of vitamin C, and their effects have been reported in a wide range of studies [12,27,[43][44][45][46][47]. The results of the meta-analysis by Li et al. [47] indicated that PCs could effectively improve the activity of anti-oxidative enzymes and reduce lipid peroxidation products. Previous studies showed that antioxidant can be useful in preventing hepatocellular damage by inhibiting lipid peroxidation by free radicals generated by heavy metals. From our data, it was shown that the mice co-treated with PCs saw increased levels of reduced GSH and higher activity of GSH-Px, and decreased the level of MDA, a result that might indicate that PCs could directly reduce phospholipid hydroperoxides within the membrane and lipoproteins by removing the ROS' ability to inhibit lipid peroxidation of liver cells induced by lead. It may also be that PCs could improve the activity of GSH-Px by activating the intracellular antioxidant signaling pathway. In addition, the reduced GSH was at, or near, control levels; the reason might be that PCs may function by increasing the steady state levels of reduced GSH and/or its rate of synthesis, thereby conferring enhanced protection against oxidative stress. Combined with our result that PCs alleviated the liver tissue histopathological variation of mice exposed to lead, we concluded that PCs, via their anti-oxidant ability, protected the liver damage caused by lead.
Currently, Nrf2 is the key molecule which mediates the response of the endogenous antioxidant system. Activation of Nrf2 can promote the expression of antioxidant genes and induce synthesis of phase II detoxifying enzymes [48]. Studies have shown that Nrf2 plays a crucial role in cellular resistance to oxidation and exogenous damage [49,50]. Recent studies have indicated that activating the Nrf2/ARE pathway has a hepato-protective effect [51,52].
In our study, we found that the gene transcription level of Nrf2 and the expression protein level of Nrf2 were both increased in the lead group. This result indicated that the expression of Nrf2 could be induced by lead under chronic lead poisoning conditions. At the same time, the results indicated that under the chronic lead poisoning, in order to cope with the oxidative stress induced by lead, the cells opened the Nrf2/ARE signal pathway to compensate for the oxidation; however, the cells were still in a state of oxidative stress. When the mice were co-treated with PCs, the nuclear Nrf2 mRNA and protein expression were also increased with a significant difference compared with that in the control group and lead group. This result indicated that PCs could activate the expression of nuclear Nrf2 protein, indicating that the effect of PCs in antagonizing lead-induced oxidative stress in liver tissue was related to the Nrf2/ARE signaling pathway.
Previous studies have suggested that a variety of cytokines and antioxidants could counteract the action of such chemicals causing up-regulation of HO-1 and γ-GCS expression [53][54][55][56][57]. γ-GCS regulated by the Nrf2/ARE signaling pathway is the rate-limiting enzyme for synthesis of GSH [54]. Heme oxygenase 1 (HO-1), a known target of Nrf2-regulated transcription and an antioxidative, cytoprotective protein in different types of cells, plays an important role in cytoprotection when oxidative stress and cellular injury occurs, and Nrf2 directly regulates its expression [55,56]. Our results showed that PCs could up-regulate the Nrf2 downstream gene HO-1 and γ-GCS expression. This indicated that PCs could improve the expression of γ-GCS, resulting in accelerating GSH synthesis in the liver, then enhancing the ability to resist the oxidative stress in liver tissue caused by lead. Combined with our results that the reduced GSH was at, or near, control levels in mice co-treated with PCs, we demonstrated that PCs could increase the amount of reduced GSH through the Nrf2/ARE signaling pathway. Our results showed that PCs could improve the expression of HO1, resulting in increasing the ability of cells to fight against oxidative stress and then maintaining the redox balance. The present results demonstrated that promotion of HO-1 expression is required for PCs' anti-oxidative effects. These results further illustrated that PCs played important roles as antioxidants and in detoxification by improving the expression of the antioxidant enzymes via the Nrf2/ARE signaling pathway. However, the molecular signaling pathway responsible for the expression of Nrf2 was not determined and is worthy of further investigation.
Apoptosis plays a key role in some metal-induced toxicity. Lead exposure can induce apoptosis of nerve cells [57], liver cells [58], and kidney cells [15] through inducing the depolarization and swelling of mitochondria, which leads to the release of cytochrome C, resulting in selective apoptosis [59].
As we know, Bcl-2 and Bax in apoptosis behave opposite to each other: Bax is a pro-apoptotic gene, while Bcl-2 is anti-apoptotic gene. Our results showed that the levels of Bcl-2 mRNA and protein were significantly down-regulated, while the expression levels of Bax were significantly up-regulated in the liver caused by lead. Our results demonstrated lead-induced liver cell apoptosis. Our results were consistent with previous investigations that hepatic apoptosis induced by low-dose exposure was associated with mitochondrial injury and changes in levels of apoptogenic proteins, such as Bcl-2, Bax, and caspase-3 [60,61]. However, PCs reversed these gene expressions, as our results showed that PCs up-regulated the anti-apoptotic gene Bcl-2 expression and down-regulated the pro-apoptotic gene Bax expression. Combined with the TUNEL assay results, we confirmed that PCs could effectively inhibit cell apoptosis in the liver.
Previous studies showed that lead could induce endoplasmic reticulum (ER) stress responses in the nervous system [62,63]. Our results demonstrated that lead induced the ER stress in the liver by increasing the expression of ER stress-related protein GRP78 and CHOP, results which were consistent with the previous study by Liu et al. [64]. Meanwhile, our results showed that mice co-treated with PCs decreased the expression of the two proteins, indicating that ER stress may be relieved by PCs treatment, which meant that PCs might protect the liver from damage by inhibiting ER stress in the liver.
Recent studies have provided evidence that PCs can be used in the treatment and prevention of diseases, such as atherosclerosis, gastric ulcers, cataracts, and diabetes. For the first time, our results suggested that the protective effect of PCs on lead-induced liver damage by inhibiting the ER stress and apoptosis is due, at least in part, to their anti-oxidant stress activity and their ability to modulate the Nrf2/ARE signaling pathway. These findings may be attributed to the manifold effects of PCs as functional foods in future applications.

Conclusions
In conclusion, PCs could protect against damage resulting from ER stress and apoptosis induced by chronic lead exposure in the liver tissue of mice. The hepatoprotective effect of PCs might be that PCs activated the expression of HO-1and γ-GCS via the Nrf2/ARE pathway, resulting in decreasing ER stress and apoptosis of the liver tissue cells.